Elevated levels of the 7-gene candidates, U2AF2, RUVBL1, HDGF, FABP4, XPO1, POSTN, and STMN1, correlate with prostate cancer biochemical recurrence and worse patient disease-free survival. This evidence concerns the gene STMN1 and prostate cancer.